![Ronald Martell](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ronald Martell
Director/Board Member at
MorphImmune, Inc.
Net worth: 61 444 $ as of 31/05/2026
Profile
Ronald A. Martell was the founder of Achieve Life Science, Inc., founded in 2015, where the title held was Chief Executive Officer from 2015 to 2017.
Mr. Martell was the founder of Orca Biosystems, Inc., founded in 2016, where the title held was Executive Chairman from 2016 to 2019.
Mr. Martell was the founder of Indapta Therapeutics, Inc., founded in 2017, where the title held was Executive Chairman from 2017 to 2022.
Mr. Martell is also the founder of Cetya Therapeutics, Inc.,Encellin, Inc...
Mr. Martell is an Independent Director at MorphImmune, Inc. since 2022.
Former positions include Chairman & Chief Executive Officer at Poniard Pharmaceuticals, Inc. in 2012; President, Chief Executive Officer & Director at Sevion Therapeutics, Inc. from 2014 to 2015; President, Chief Executive Officer & Director at NeurogesX, Inc. from 2012 to 2013; President, Chief Executive Officer & Director at Nuvelution Pharma, Inc. from 2019 to 2021; President, Chief Executive Officer & Director at Jasper Therapeutics, Inc. from 2022 to 2026; Executive Chairman at Humanigen, Inc. in 2015; Executive Chairman at Kalobios Pharmaceuticals, Inc. in 2015; Independent Director at Plus Therapeutics, Inc. from 2016 to 2019; Group Manager-Oncology Products at Genentech, Inc. from 1988 to 1998; Senior Vice President-Commercial Operations at ImClone LLC from 1998 to 2006.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 31/03/2026 | 74,118 ( 0.26% ) | 61 444 $ | 31/05/2026 |
Ronald Martell active positions
| Companies | Position | Start |
|---|---|---|
MorphImmune, Inc.
 MorphImmune, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focused on developing oncology therapeutics | Director/Board Member | 12/04/2021 |
Former positions of Ronald Martell
| Companies | Position | End |
|---|---|---|
| JASPER THERAPEUTICS, INC. | Chief Executive Officer | 05/01/2026 |
Indapta Therapeutics, Inc.
 Indapta Therapeutics, Inc. BiotechnologyHealth Technology Develops proprietary, off-the-shelf, allogeneic natural killer cell therapy to treat cancer | Founder | 01/03/2022 |
Nuvelution Pharma, Inc.
 Nuvelution Pharma, Inc. BiotechnologyHealth Technology Provides solutions for R&D companies in the pharmaceutical and biotech industries | Chief Executive Officer | 01/03/2021 |
| PLUS THERAPEUTICS, INC. | Director/Board Member | 21/12/2019 |
Orca Biosystems, Inc.
 Orca Biosystems, Inc. BiotechnologyHealth Technology Develops allogeneic T-cell immunotherapies for the treatment of blood cancers | Founder | 01/06/2019 |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
58
1st degree connections
16
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 16 |
|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology Develops novel therapeutic products and blood cell growth factors for the treatment of cancer | Health Technology |
Poniard Pharmaceuticals, Inc.
 Poniard Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops therapeutic biopharmaceuticals, primarily for the treatment of cancer, cardiovascular and inflammatory diseases | Health Technology |
Sevion Therapeutics, Inc.
 Sevion Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops genetic technology for agricultural and medical applications | Commercial Services |
Humanigen, Inc.
 Humanigen, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that engages in development of cell and gene therapies for treatment of cancers and infectious diseases | Health Technology |
NeurogesX, Inc.
 NeurogesX, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel pain management therapies | Health Technology |
Plus Therapeutics, Inc.
 Plus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops radio therapeutics products | Health Technology |
Cetya Therapeutics, Inc.
 Cetya Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Nuvelution Pharma, Inc.
Nuvelution Pharma, Inc. BiotechnologyHealth Technology Provides solutions for R&D companies in the pharmaceutical and biotech industries | Health Technology |
Achieve Life Science, Inc.
 Achieve Life Science, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Orca Biosystems, Inc.
Orca Biosystems, Inc. BiotechnologyHealth Technology Develops allogeneic T-cell immunotherapies for the treatment of blood cancers | Health Technology |
Encellin, Inc.
 Encellin, Inc. Medical SpecialtiesHealth Technology Develops novel thin-film cell encapsulation device for cell-based therapeutics | Health Technology |
Indapta Therapeutics, Inc.
Indapta Therapeutics, Inc. BiotechnologyHealth Technology Develops proprietary, off-the-shelf, allogeneic natural killer cell therapy to treat cancer | Health Technology |
MorphImmune, Inc.
MorphImmune, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focused on developing oncology therapeutics | Health Technology |
Jasper Therapeutics, Inc.
 Jasper Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company which engages in enabling cures through hematopoietic stem cell therapy | Health Technology |
Kalobios Pharmaceuticals, Inc. | Technology Services |
- Stock Market
- Insiders
- Ronald Martell
